Showing 1 - 10 of 2,788
Persistent link: https://www.econbiz.de/10011809662
Persistent link: https://www.econbiz.de/10013410987
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012585624
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012589862
Persistent link: https://www.econbiz.de/10012647934
Persistent link: https://www.econbiz.de/10012591832
The COVID-19 shock hit firms hard, on average, but how did it hit in the distribution of firms, differently between the high-growth superstars and the firms that were already struggling to survive? This paper implements graphical techniques and quantile regression to analyse the effect of the...
Persistent link: https://www.econbiz.de/10014342072
Persistent link: https://www.econbiz.de/10013390735
Persistent link: https://www.econbiz.de/10014302713
This study investigates the effects of social distancing measures on various types of social mobility, using country- and day-fixed effects on a panel of daily data comprising 29 European countries. Although social distancing measures proved to be significant for all types of mobility in the...
Persistent link: https://www.econbiz.de/10014320267